Covington & Burling represented uniQure in the transaction. uniQure N.V. (NASDAQ: QURE), a leading gene therapy company, announced the closing of the sale of its global...
Genezen’s Acquisition of Gene Therapy Manufacturing Facility
Alexion, AstraZeneca Rare Disease in Deal with Pfizer
Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...